S1 Research (Step One Ventures)
F·40Catalog skews to large-vial cosmetic raws; positioning still under review.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
- Testing methods
- Not publicly disclosed.
- Testing lab
- Not publicly disclosed.
- Most recent COA
- Not publicly posted.
- OpenAssay score ↗
- — pending integration with openassay.org.
- Testing transparency10/40
Public 7-category testing rubric grade plus disclosed testing methods plus a named third-party lab. The full range is gated on the vendor publicly naming the tests they run; a high rubric grade without disclosure caps at 18 of 40.
- Operational & regulatory standing6/25
Reflects FDA actions, payment-processor issues, ownership uncertainty, closures, and editorial audit notes the vendor-risk monitor has surfaced. A recent published COA earns a small bonus on top of the operational base.
- Operational stability8/15
Vendor age. 5+ years of operation earns full points; 1 year or less earns minimal credit. Absent foundedYear earns a neutral default; absence of data is not proof of risk.
- Verification tier6/10
Editorial tier assignment based on documentation completeness, response to corrections, and presence of verifiable business address. Tier 1 vendors meet the highest bar.
- Price discipline10/10
Heuristic check on aggressive discounting. Reasonable codes (<=25%) earn full points; 25-40% earns half; >40% off list often signals inventory clearance or churn and earns zero.
- Catalog skews toward large-vial cosmetic raw materials rather than research-dose vials; verify SKU-level packaging before relying on listed prices.
Editorial observations recorded during our vendor review. Send corrections to corrections@pepticker.com.
- ✓Identity verified
- ✓Net content confirmed
- ✓Net purity ≥ 97%
- ✓Endotoxin tested
- ·Sterility tested
- ·Heavy metals screened
- ·Conformity documented
Our vendor-risk monitor tracks closures, payment-processor issues, FDA actions, and community sentiment.
S1R1010% offTracked SKUs
39 listings| Peptide | Size | Price | $/mg | Status |
|---|---|---|---|---|
| 5-Amino-1MQ | 50mg | $48.00 | $0.96 | In stock |
| AOD-9604 | 5mg | $45.00 | $9.00 | In stock |
| BPC-157 | 10mg | $28.00 | $2.80 | In stock |
| BPC-157 + TB-500 (Wolverine Blend) | 20mg | $60.00 | $3.00 | Out |
| Cagrilintide | 5mg | $40.00 | $8.00 | In stock |
| Cagrilintide | 10mg | $65.00 | $6.50 | In stock |
| CJC-1295 + Ipamorelin Blend | 10mg | $50.00 | $5.00 | Out |
| DSIP | 5mg | $27.00 | $5.40 | In stock |
| Epitalon | 10mg | $28.00 | $2.80 | In stock |
| GHK-Cu | 100mg | $39.00 | $0.39 | In stock |
| Glow | 70mg | $60.00 | $0.86 | In stock |
| Glutathione | 1500mg | $60.00 | $0.04 | In stock |
| IGF-1 LR3 | 1mg | $50.00 | $50.00 | Out |
| Ipamorelin | 10mg | $40.00 | $4.00 | In stock |
| KLOW | 80mg | $70.00 | $0.88 | In stock |
| KPV | 10mg | $35.00 | $3.50 | In stock |
| MOTS-c | 10mg | $45.00 | $4.50 | In stock |
| MOTS-c | 40mg | $75.00 | $1.88 | In stock |
| N-Acetyl Semax Amidate | 10mg | $45.00 | $4.50 | In stock |
| NAD+ | 500mg | $50.00 | $0.10 | In stock |
| NAD+ | 1000mg | $70.00 | $0.07 | In stock |
| PT-141 | 10mg | $35.00 | $3.50 | In stock |
| Retatrutide | 10mg | $60.00 | $6.00 | In stock |
| Retatrutide | 20mg | $70.00 | $3.50 | In stock |
| Retatrutide | 30mg | $120.00 | $4.00 | In stock |
| Retatrutide | 60mg | $165.00 | $2.75 | In stock |
| Semaglutide | 5mg | $29.00 | $5.80 | In stock |
| Semaglutide | 10mg | $45.00 | $4.50 | In stock |
| Sermorelin | 5mg | $40.00 | $8.00 | In stock |
| Sermorelin | 10mg | $60.00 | $6.00 | Out |
| SS-31 | 50mg | $99.00 | $1.98 | In stock |
| TB-500 | 10mg | $50.00 | $5.00 | In stock |
| TB-500 Fragment 17-23 | 10mg | $40.00 | $4.00 | In stock |
| Tesamorelin | 10mg | $55.00 | $5.50 | In stock |
| Thymosin Alpha-1 | 10mg | $60.00 | $6.00 | In stock |
| Tirzepatide | 10mg | $40.00 | $4.00 | In stock |
| Tirzepatide | 30mg | $70.00 | $2.33 | In stock |
| Tirzepatide | 60mg | $120.00 | $2.00 | In stock |
| Tirzepatide | 140mg | $179.00 | $1.28 | In stock |
More on S1 Research (Step One Ventures) & similar vendors
- Tirzepatide— Dual GLP-1/GIP agonist
- Retatrutide— Triple GCG/GIP/GLP-1 agonist
- NAD+— Mitochondrial-cofactor research compound
- MOTS-c— Mitochondrial exerkine
- Semaglutide— GLP-1 agonist for metabolic research
- Swole AF Labs— Tier 2 · score 5.0/7
- Peptide Hub— Tier 2 · score 5.0/7
- Modern Research Peptides— Tier 2 · score 5.5/7